Measuring the Functional Impact of Behavioral Inflexibility in Children with Autism Using the Behavioral Inflexibility Scale: Clinical Interview (BIS-CI) / James W. BODFISH in Journal of Autism and Developmental Disorders, 52-2 (February 2022)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 52-2 (February 2022) . - p.782-790 Titre : Measuring the Functional Impact of Behavioral Inflexibility in Children with Autism Using the Behavioral Inflexibility Scale: Clinical Interview (BIS-CI) Type de document : Texte imprimé et/ou numérique Auteurs : James W. BODFISH, Auteur ; L. LECAVALIER, Auteur ; C. HARROP, Auteur ; Aaron R. DALLMAN, Auteur ; Sahana Nagabhushan KALBURGI, Auteur ; J. HOLLWAY, Auteur ; R. FALDOWSKI, Auteur ; Brian A. BOYD, Auteur Article en page(s) : p.782-790 Langues : Anglais (eng) Mots-clés : Adolescent  Autism Spectrum Disorder  Autistic Disorder  Child  Child, Preschool  Factor Analysis, Statistical  Humans  Parents  Reproducibility of Results  Autism spectrum disorder  Behavioral inflexibility  Measurement  Outcomes  Repetitive behavior Index. décimale : PER Périodiques Résumé : For individuals with autism spectrum disorder (ASD), behavioral inflexibility can affect multiple domains of functioning and family life. The objective of this study was to develop and validate a clinical interview version of the Behavioral Inflexibility Scale. Trained interviewers conducted interviews with parents of 144 children with ASD and 70 typically developing children (ages: 3-17 years). Using exploratory factor analysis, the Behavioral Inflexibility Scale-Clinical Interview (BIS-CI) was found to be unidimensional. Reliability data indicated the measure was internally consistent (??=?0.80), achieved excellent inter-rater reliability (ICC?=?0.97) and test-retest reliability (ICC?=?0.87). These findings demonstrate that the BIS-CI is a reliable and valid measure to determine the functional impact of behavioral inflexibility. En ligne : http://dx.doi.org/10.1007/s10803-021-04984-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=455 [article] Measuring the Functional Impact of Behavioral Inflexibility in Children with Autism Using the Behavioral Inflexibility Scale: Clinical Interview (BIS-CI) [Texte imprimé et/ou numérique] / James W. BODFISH, Auteur ; L. LECAVALIER, Auteur ; C. HARROP, Auteur ; Aaron R. DALLMAN, Auteur ; Sahana Nagabhushan KALBURGI, Auteur ; J. HOLLWAY, Auteur ; R. FALDOWSKI, Auteur ; Brian A. BOYD, Auteur . - p.782-790. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 52-2 (February 2022) . - p.782-790 Mots-clés : Adolescent  Autism Spectrum Disorder  Autistic Disorder  Child  Child, Preschool  Factor Analysis, Statistical  Humans  Parents  Reproducibility of Results  Autism spectrum disorder  Behavioral inflexibility  Measurement  Outcomes  Repetitive behavior Index. décimale : PER Périodiques Résumé : For individuals with autism spectrum disorder (ASD), behavioral inflexibility can affect multiple domains of functioning and family life. The objective of this study was to develop and validate a clinical interview version of the Behavioral Inflexibility Scale. Trained interviewers conducted interviews with parents of 144 children with ASD and 70 typically developing children (ages: 3-17 years). Using exploratory factor analysis, the Behavioral Inflexibility Scale-Clinical Interview (BIS-CI) was found to be unidimensional. Reliability data indicated the measure was internally consistent (??=?0.80), achieved excellent inter-rater reliability (ICC?=?0.97) and test-retest reliability (ICC?=?0.87). These findings demonstrate that the BIS-CI is a reliable and valid measure to determine the functional impact of behavioral inflexibility. En ligne : http://dx.doi.org/10.1007/s10803-021-04984-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=455

Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder / L. LECAVALIER in Journal of Autism and Developmental Disorders, 48-4 (April 2018)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 48-4 (April 2018) . - p.980-987 Titre : Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : L. LECAVALIER, Auteur ; X. PAN, Auteur ; T. SMITH, Auteur ; B. L. HANDEN, Auteur ; L. Eugene ARNOLD, Auteur ; L. SILVERMAN, Auteur ; R. V. TUMULURU, Auteur ; J. HOLLWAY, Auteur ; Michael G. AMAN, Auteur Article en page(s) : p.980-987 Langues : Anglais (eng) Mots-clés : Atomoxetine  Attention deficit hyperactivity disorder  Autism spectrum disorder  Parent stress  Parent training Index. décimale : PER Périodiques Résumé : We previously reported a 2 x 2 randomized clinical trial of atomoxetine (ATX) and parent training (PT) for attention deficit hyperactivity disorder (ADHD) symptoms and behavioral noncompliance in 128 children with autism spectrum disorder, ages 5-14 years. Children were randomized to one of four conditions: ATX alone, placebo alone, ATX + PT, or PT + placebo. Both ATX and PT improved some indices of ADHD and behavioral compliance. In this report, we describe parent stress over time and across conditions. All four treatments improved parent self-rated stress from baseline to week 10. However, there were no statistically significant differences between treatment groups. Significantly more improvement in parent stress scores was observed for clinical responders than non-responders. ClinicalTrials.gov Title: Atomoxetine, Placebo and Parent Management Training in Autism (Strattera) ClinicalTrials.gov Identifier: NCT00844753. En ligne : http://dx.doi.org/10.1007/s10803-017-3345-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=351 [article] Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder [Texte imprimé et/ou numérique] / L. LECAVALIER, Auteur ; X. PAN, Auteur ; T. SMITH, Auteur ; B. L. HANDEN, Auteur ; L. Eugene ARNOLD, Auteur ; L. SILVERMAN, Auteur ; R. V. TUMULURU, Auteur ; J. HOLLWAY, Auteur ; Michael G. AMAN, Auteur . - p.980-987. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 48-4 (April 2018) . - p.980-987 Mots-clés : Atomoxetine  Attention deficit hyperactivity disorder  Autism spectrum disorder  Parent stress  Parent training Index. décimale : PER Périodiques Résumé : We previously reported a 2 x 2 randomized clinical trial of atomoxetine (ATX) and parent training (PT) for attention deficit hyperactivity disorder (ADHD) symptoms and behavioral noncompliance in 128 children with autism spectrum disorder, ages 5-14 years. Children were randomized to one of four conditions: ATX alone, placebo alone, ATX + PT, or PT + placebo. Both ATX and PT improved some indices of ADHD and behavioral compliance. In this report, we describe parent stress over time and across conditions. All four treatments improved parent self-rated stress from baseline to week 10. However, there were no statistically significant differences between treatment groups. Significantly more improvement in parent stress scores was observed for clinical responders than non-responders. ClinicalTrials.gov Title: Atomoxetine, Placebo and Parent Management Training in Autism (Strattera) ClinicalTrials.gov Identifier: NCT00844753. En ligne : http://dx.doi.org/10.1007/s10803-017-3345-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=351

---

1 (1 - 2 / 2)